Skip to main content

Kirske David's Form 4 filing

Cti Biopharma Corp (CTIC) · filed Jun 17, 2022

Accession no.
0000891293-22-000033
Filed
Jun 17, 2022
Trade date
Jun 17, 2022
Filing delay
Same day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $372.5K. It was filed on the trade date.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Kirske DavidCIK 0001276750Officer (EVP, Chief Financial Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 17, 2022common stockMOption exerciseAcquired+10,000$1.00+$10,00017,397Direct
Jun 17, 2022common stockSSaleDisposed−10,000$6.00−$60,0007,397Direct
Jun 17, 2022common stockMOption exerciseAcquired+50,000$3.30+$165,00057,397Direct
Jun 17, 2022common stockSSaleDisposed−50,000$6.25−$312,5007,397Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jun 17, 2022Common StockMOption exerciseDisposed−10,000$0.00$0340,000Direct
Jun 17, 2022Common StockMOption exerciseDisposed−50,000$0.00$0150,000Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)